Corbion and MedinCell form joint venture to supply resorbable polymers for controlled drug release

August 10, 2015 01:00 ET | Source: Corbion Corbion

Corbion and MedinCell are establishing a 50/50 joint venture for the supply of PEG (polyethyleneglycol) and PLA (polylactic acid) based co-polymers in the field of controlled release drug delivery.

Attachments

pdf-version of press release...

Recommended Reading

November 20, 2025 01:00 ET | Source: Corbion

Corbion unveils BRIGHT 2030 strategy to lead in sustainable specialty food-ingredients; outlining its strategic path and medium-term financial targets

Corbion, the Amsterdam-listed sustainable food-ingredients company that champions preservation through application of science, will hold its Capital Markets Day for analysts and investors via live...
Read More
November 12, 2025 01:00 ET | Source: Corbion

Corbion reports the end of its share buyback program to cover commitments under its long-term employee incentive plan

Corbion, the Amsterdam-listed sustainable ingredients company that champions preservation through application of science, today announces that it has completed the share buyback program which it...
Read More